Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Sayed et al
- PMID: 38649281
- PMCID: PMC11043714
- DOI: 10.1136/jitc-2024-009137
Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Sayed et al
Keywords: Cardiotoxicity; T cell; Treatment related adverse event - trAE.
Conflict of interest statement
Competing interests: All authors declare that they have no conflicts of interest.
Comment in
-
Response to: Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Noguchi et al.J Immunother Cancer. 2024 Apr 22;12(4):e009300. doi: 10.1136/jitc-2024-009300. J Immunother Cancer. 2024. PMID: 38649282 Free PMC article. No abstract available.
Comment on
-
Cardiovascular toxicities associated with bispecific T-cell engager therapy.J Immunother Cancer. 2024 Feb 21;12(2):e008518. doi: 10.1136/jitc-2023-008518. J Immunother Cancer. 2024. PMID: 38388168 Free PMC article.
References
-
- CIOMS Working Group VIII . Practical aspects of signal detection in Pharmacovigilance. CIOMS; 2010.
-
- Urushihara H. Basic dos and don’ts in applying signal detection methods to spontaneous reporting systems databases. Jpn J Drug Inform 2019;21:135–41. 10.11256/jjdi.21.135 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources